Teladoc (TDOC) Stock Drops After Disappointing Q2 Earnings
Teladoc Health Inc. (TDOC) reported weaker-than-expected fiscal second-quarter earnings and revenue, leading to a sharp decline in its stock price on July 30, 2026. The telehealth company lost $0.21 per share for the quarter with total revenue of $607 million, marking a 4% year-over-year drop. A significant contributor to this underperformance was the BetterHelp segment's direct-to-consumer mental health services, which saw an annual decline in revenue by 12%. The CEO attributed part of the issue to capacity constraints limiting conversions from member interest into billed sessions. Teladoc also revised its full-year sales guidance downward, projecting a range between $2.36 billion and $2.45 billion. Despite these challenges, Wall Street analysts maintain a 'Moderate Buy' rating for TDOC stock with an average price target of around $8 per share. The derivatives market shows optimism as well, suggesting potential upside in the coming months.
Tickers: $TDOC
Topics: betterhelp revenue_decline telehealth